M

McKesson Europe AG
XHAM:CLS1

Watchlist Manager
McKesson Europe AG
XHAM:CLS1
Watchlist
Price: 24.4 EUR Market Closed
Market Cap: €5B

Gross Margin

10.3%
Current
No historical data
Comparison unavailable

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
10.3%
=
Gross Profit
€2.1B
/
Revenue
€20.6B

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
10.3%
=
Gross Profit
€2.1B
/
Revenue
€20.6B

Peer Comparison

Country Company Market Cap Gross
Margin
DE
McKesson Europe AG
XHAM:CLS1
5B EUR
Loading...
US
Mckesson Corp
NYSE:MCK
116.2B USD
Loading...
US
Amerisourcebergen Corp
LSE:0HF3
70.3B USD
Loading...
US
Cencora Inc
NYSE:COR
69.8B USD
Loading...
US
Cardinal Health Inc
NYSE:CAH
52.8B USD
Loading...
AU
Sigma Healthcare Ltd
ASX:SIG
33.8B AUD
Loading...
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
63.6B CNY
Loading...
CN
Huadong Medicine Co Ltd
SZSE:000963
63.1B CNY
Loading...
US
Henry Schein Inc
NASDAQ:HSIC
9.3B USD
Loading...
CN
Sinopharm Group Co Ltd
HKEX:1099
65.8B HKD
Loading...
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
Loading...

Market Distribution

Lower than 95% of companies in Germany
Percentile
5th
Based on 3 457 companies
5th percentile
10.3%
Low
-5 776.5% — 29.1%
Typical Range
29.1% — 60.9%
High
60.9% — 184.7%
Distribution Statistics
Germany
Min -5 776.5%
30th Percentile 29.1%
Median 44.6%
70th Percentile 60.9%
Max 184.7%

McKesson Europe AG
Glance View

Market Cap
5B EUR
Industry
Health Care

McKesson Europe AG traces its roots back over a century, intertwining its growth story with the evolving landscape of healthcare in Europe. As a pivotal player in the distribution and retail of pharmaceuticals, McKesson Europe bridges the critical gap between manufacturers and patients. They operate a vast network of pharmacies spread across numerous countries, alongside an extensive distribution system. This infrastructure ensures medicines and health products swiftly reach their destinations, whether it be sprawling urban areas or remote rural locales. Through this network, McKesson Europe not only guarantees the delivery of essential drugs but also emphasizes efficiency and reliability, crafting a reputation that enhances its commercial success. Revenue streams for McKesson Europe derive from its multifaceted approach to healthcare services. The company thrives on both the wholesaling aspect, where it supplies drugs and health products to independent pharmacies and hospitals, and its retail operations through pharmacy chains. Moreover, McKesson Europe extends its business model by providing management services to independent pharmacies, optimizing their operations and supply chains. With the ever-growing demand for healthcare solutions in Europe, the company capitalizes on this pressing need, utilizing its vast logistical capabilities and deep industry knowledge to maintain its position as a leader in the pharmaceutical distribution and retail sectors. This strategic combination of services enables McKesson Europe AG to sustain its business momentum, adapting to the changing needs of the healthcare market.

CLS1 Intrinsic Value
Not Available
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
10.3%
=
Gross Profit
€2.1B
/
Revenue
€20.6B
How has Gross Margin changed over time?

Over the last 3 years, McKesson Europe AG’s Gross Margin has decreased from 11% to 10.3%. During this period, it reached a low of 10.3% on Apr 3, 2017 and a high of 11.1% on Dec 31, 2015.

Back to Top